Capitol Hill Report
Advocacy
Read the Academy's bi-weekly update on legislative and regulatory advocacy for neurology.
October 7, 2024
Your Advocacy Impact
Issue in Focus
The 2024 elections will be here before you know it! As neurologists and health care professionals, you are in a prime position to drive civic engagement, starting with a simple yet powerful action—. Your vote can influence policies that directly affect the health care system, your patients, and the broader community. At all levels of government, there are candidates who can affect your patients, your practice, and your profession. That’s why it’s so important to make sure you are registered to vote and know the rules and regulations for voting in your area. If you recently moved, need a refresher, or just want to be 100% sure you’re set for Election Day, please visit and learn more.
BrainPAC is Fighting for the Profession Every Day
Are you familiar with ? BrainPAC is the political action committee affiliated with the AAN, and the only political action committee serving neurology and its patients. Eligible AAN members in the US can contribute to BrainPAC, and 100% of those funds go to bipartisanly support the champions of neurology running for the US Congress. BrainPAC not only helps those champions return but allows us to build stronger relationships with them— both in Washington, DC, and in their home states—and to educate them about the issues facing the practice of neurology. From access to care, to the neurology workforce, to administrative burdens like prior authorization and step therapy, BrainPAC is working tirelessly on the Hill to help you and your patients. about our work and how we fight for neurology every day on Capitol Hill.
Want to Do More?
Take your advocacy to the next level by applying for Neurology on the Hill when applications open on October 10th. It’s your chance to meet with lawmakers and shape the future of neurology and patient care. This program gives you the skills you need to meet with your lawmakers, then sends you to Capitol Hill to put your training into practice. Together, we can make a difference—from the clinic to Congress—by registering to vote, learning about BrainPAC, and attending Neurology on the Hill.
If you have any questions about BrainPAC or AAN advocacy programs, please don’t hesitate to contact us at advocacy@aan.com.
Latest Advocacy News
California NeuroRights Bill Signed into Law
Last week, California Governor Gavin Newsom signed SB 1223, known as the NeuroRights bill, into law. The new law, supported by the AAN, passed both the State Assembly and Senate without opposition. It amends the state’s current personal privacy law by specifically including protections for neural data. This is the second bill of its kind in the US, following similar legislation passed earlier this year in Colorado.
AAN Submits Comments in Support of Electronic Prior Authorization
On October 3, the AAN submitted comments in response to a proposed rule from the Assistant Secretary for Technology Policy and the Office of the National Coordinator for Health Information Technology (ASTP/ONC) updating policies related to electronic health record (EHR) conditions of certification and the statutory prohibition on information blocking. The AAN’s comments supported requirements relating to EHR support for electronic prior authorization transactions and real-time prescription benefit information. The AAN also provided technical feedback on proposals impacting the various exceptions to the information blocking prohibition.
Government Funded Through December 20
On September 25, 2024, both the House and Senate passed a continuing resolution to provide government funding through December 20, 2024. This will allow the government to remain open until a final FY2025 appropriations package can be negotiated.
AAN Urges CMS to Address Telehealth Reporting Requirements
On October 2, in coordination with over 150 partner organizations, the AAN urged the Centers for Medicare and Medicaid Services (CMS) to address inappropriate reporting requirements for providers without a physical practice other than their home. In urging CMS to resolve this issue, the letter noted that it is not practical, workable, or safe to require a provider to report their home address as their practice location and that Medicare providers who deliver care via telehealth should not be compelled to do so.
What We're Reading
• The Medicare Advantage Influence Machine ()
• Inflation Reduction Act rebates yield savings for 54 Medicare Part B drugs ()
Capitol Hill Report Archives
2024
- September 23: Brain Health for All!
- September 9: AAN Comments on Medicare Fee Schedule
- August 26: Physicians Are Essential In Local Advocacy
- August 12: Ask Congress to Take Action for Telehealth
- July 22: Urge Congress to Prevent Proposed Cut
- July 8: Advocate for Neurology from Your Home State!
- June 24: Crucial Prior Authorization Bill Introduced in Congress
- June 10: Senate Group to Discuss Medicare Payment Reform
- May 20: 30 Years of Conrad 30
- May 6: Lobbyist for a Day
- April 22: Congress Considers Access to Care
- April 8: AAN Recommends More Transparency in Medicare Advantage
- March 25: AAN Identifies Top Advocacy Priorities
- March 11: Congress Acts on Medicare Cuts
- February 26: Could Your Advocacy Go Even Further at the State Level?
- February 12: Neurology on the Hill Preview
- January 22: Medicare Reimbursement Update
- January 8: 2023 Advocacy Year in Review
2023
- December 11: Take Action to Prevent Damaging Reimbursement Cuts!
- November 20: AAN Members Provide Perspective at AMA Meeting
- November 6: How Will the CMS Fee Schedule Affect You?
- October 23: Reps Hear Proposal to Cut 'Red Tape'
- October 9: Participant Goes from Training to Testimony
- September 25: AAN Leaders Take the Hill
- September 11: AAN Submits Comments on 2024 Medicare Physician Fee Schedule
- August 21: Proposed Code Will Help CMS Value Cognitive Care Services
- August 7: Reinforcements Are on the Way!
- July 24: AAN President Elect Testifies on New Alzheimer's Treatments
- July 10: FDA Approves Lecanemab for Alzheimer's Disease
- June 26: MACRA, Prior Authorization, and AMA Resolutions
- June 12: Debt Limit Deal Affects Dollars for Research
- May 22: Want Step Therapy Reform? Please Step Forward!
- May 8: Act Now to Protect Veteran Care, Medicare Reimbursement
- April 24: Do You Know the AAN's 2023 Advocacy Priority Issues?
- April 10: AAN Responds to Health Workforce Crisis Inquiry
- March 20: Working with CMS on Monoclonal Antibodies Coverage
- March 6: Support Your 180 Colleagues Now Advocating in DC
- February 20: Capitol Hill Report: AAN Addresses National, State Health Care Issues
- February 6: Confronting Prior Authorization Burden, End of PHE
- January 23: Advisory Committee Supports Medicare Reimbursement Increases
- January 9: Top AAN Advocacy Successes in 2022
2022
- December 23: Congress Enacts Bill with Key Advocacy Wins
- December 12: AAN Monitoring Lecanemab for Alzheimer's Disease
- November 21: How the Midterms Will Impact Neurology
- November 7: Advocacy Strengthens Neurology—Join Us!
- October 24: Urge Senate to Act on Medicare Payment Stability
- October 10: Get Involved in Neurology Advocacy
- September 26: Physician Lawmakers Seek to Stem Medicare Reductions
- September 12: AAN Comments on Proposed 2023 Medicare Physician Fee Schedule
- August 22: Administration Outlines Federal Response to Long COVID
- August 8: Congress Makes Progress on Neurology Issues
- July 25: AAN Urges Congress to Focus on Long COVID; Joined by 75 Organizations
- July 11: CMS Proposes Changes to Telehealth, E/M, QPP, More
- June 20: AAN Input Helps Shape AMA Policies
- June 6: Congressional Support Grows for Key AAN Legislation.
- May 23: It's Time for Neurology on the Hill!
- May 9: Focus Is on Three Issues for Neurology on the Hill
- April 25: Pushing Congress for More
- April 11: Congress Addressing AAN Priorities
- March 21: AAN Active on Legislation, Research Funding
- March 7: Members Make Their Advocacy Priorities Clear
- February 21: Legislation on Prior Authorization Gains Support
- February 7: Loosened Telehealth Policies in Peril
- January 24: COVID-19 Vaccinations, Aducanumab, and More
- January 10: Improving Care for Veterans With Neurological Conditions
2021
- December 28: Top 10 AAN Advocacy Successes
- December 6: Inching Closer to the Medicare Cliff
- November 22: BBB Act Reduces Medicare Drug Costs, Bolsters Physician Pipeline
- November 8: Biden Boost BBB; CMS Sets Final Fee Schedule
- October 25: Medicare Cliff: Will Congress Save Us—Or Push Us Over?
- October 12: Advocacy with FDA, CMS, CDC, AND Congress Produces Results
- September 20: Responding to Medicare 'Cliff,' Proposed Fee Schedule, More
- August 23: Advocacy Action on National, State Levels
- August 9: Support For Vaccine Mandates, Diversity in Clinical Trials
- July 26: Latest Efforts on Telehealth, Aducanumab, Medicare Fee Schedule
- July 12: New Bills Would Affect Telehealth, Drug Pricing, Residents
- June 21: Help Act to Increase Transparency and Streamline Prior Authorization
- June 7: FDA Approves Aducanumab for Alzheimer's Disease
- May 24: Members Lobby DC Lawmakers From Afar
- May 10: Zeroing in on Reimbursement, Telemedicine, and Lower Drug Prices
- April 26: Research Appropriations, Telehealth Policies, Open Payments, and New Staff
- April 12: Connect with AAN Advocacy at Annual Meeting
- March 22: Take Action to Delay Upcoming Medicare Payment Cuts
- March 8: Good News for MIPS Participants
- February 22: House Vote Near on COVID-19 Relief Bill
- February 8: Neurology Advocates Begin Educating New Members of Congress
- January 25: Leadership Transfers Peacefully in Nation’s Capital
- January 11: New Congress Brings Power Shift to DC